Neurochemical analysis of the tyrosine hydroxylase expression in methamphetamine-sensitized rats

Annals of the New York Academy of Sciences

Volumn 801, Issue , 1996, Pages 371-376

  Fukamauchi, F ^a   Ishimaru, M ^a   Hashimoto, T ^b   Obata, K ^c  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^c NATIONAL INSTITUTE FOR PHYSIOLOGICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; MESSENGER RNA; METHAMPHETAMINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; DOPAMINE METABOLISM; DOPAMINERGIC NERVE CELL; IN SITU HYBRIDIZATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MESENCEPHALON; NEUROCHEMISTRY; NONHUMAN; NORTHERN BLOTTING; PERIKARYON; RAT; SUBSTANTIA NIGRA; VENTRAL TEGMENTUM;

ANIMALIA;

EID: 0030450426     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb17457.x     Document Type: Conference Paper

References (13)

1. SNYDER, S. H. 1972. Catecholamines in the brain as mediators of amphetamine psychosis. Arch. Gen. Psychiatry 27: 169-179.
2. KALIVAS, P. W. & J. STEWART. 1991. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res. Rev. 16: 223-244.
3. ROBINSON, T. E. & J. B. BECKER. 1986. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res. Rev. 11: 157-198.
4. DOUGHERTY, G. G. & E. H. ELLINWOOD. 1983. Influence of gamma-butyrolactone on behavior due to dopaminergic drugs. Physiol. Behav. 30: 607-612.
5. SHIRAO, T., M. J. EVINGER, L. IACOVITTI & D. J. REIS. 1992. Lesions of nigrostriatal pathway reduce expression of tyrosine hydroxylase gene in residual dopaminergic neurons of substantia nigra. Neurosci. Lett. 141: 208-212.
6. CHOMCZYNSKI, P. & N. SACCHI. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159.
7. FEINBERG, A. P. & B. VOGELSTEIN. 1983. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132: 6-13.
8. SEIDEN, L. S. & K. E. SABOL. 1993. Amphetamine: effects on catecholamine systems and behavior. Annu. Rev. Pharmacol. Toxicol. 32: 639-677.
9. TORU, M., T. NISHIKAWA, M. TAKASHIMA & N. MATAGA. 1982. Studies on tyrosine hydroxylase in dopaminergic nerve terminals including mesolimbic and mesocortical areas. Adv. Biosci. 37: 107-121.
10. NISHIKAWA, T., N. MATAGA, M. TAKASHIMA & M. TORU. 1983. Behavioral sensitization and relative hyperresponsiveness of striatal and limbic dopaminergic neurons after repeated methamphetamine treatment. Eur. J. Pharmacol. 88: 195-203.
11. HOTCHKISS, A. J., M. E. MORGAN & J. W. GIBB. 1979. The long-term effects of multiple doses of methamphetamine on neostriatal tryptophan hydroxylase, tyrosine hydroxylase, choline acetyltransferase and glutamate decarboxylase activities. Life Sci. 25: 1373-1378.
12. ELLISON, G., M. S. EISON, H. S. HUBERMAN & F. DANIEL. 1978. Long-term changes in dopaminergic innervation of caudate nucleus after continuous amphetamine administration. Science 201: 276-278.
13. ELLISON, G. 1992. Continuous amphetamine and cocaine have similar neurotoxic effects in lateral habenular nucleus and fasciculus retroflexus. Brain Res. 598: 353-356.